Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mohsen Beheshti1

  • 1Department of Nuclear Medicine and Endocrinology, PET - CT Center LINZ, Ordensklinikum, St Vincent's Hospital, Seilerstaette 4, Linz A-4020, Austria; Department of Nuclear Medicine and Endocrinology, Paracelsus Medical University, Muellner Hauptstrasse 48, Salzburg A-5020, Austria.

PET Clinics
|September 17, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer.

Seminars in nuclear medicine·2026
Same author

Incidental finding of central pontine myelinolysis on [<sup>18</sup>F]FDG PET/CT.

European journal of nuclear medicine and molecular imaging·2026
Same author

The Role of FAPI PET/CT in the Assessment of Inflammatory Diseases.

Seminars in nuclear medicine·2026
Same author

Fibroblast Activation Protein Inhibitor (FAPI)-Radioligand PET/CT in the Assessment of Nononcological Diseases: A Narrative Review.

ACS pharmacology & translational science·2025
Same author

The role of non-FDG agents in PET imaging of bladder cancer.

Seminars in nuclear medicine·2025
Same author

Experimental approach for optimizing dose regimen of 68Ga-DOTATATE PET/CT for neuroendocrine tumor (NET) imaging in current high sensitivity scanners: Phantom and Patient Study.

Nuklearmedizin. Nuclear medicine·2025

18F-sodium fluoride (18F-NaF) PET/CT offers accurate bone imaging for diseases. Its high performance and increasing availability suggest it could become a standard for skeletal assessments, especially for cancers.

Area of Science:

  • Nuclear medicine
  • Radiology
  • Oncology

Background:

  • 18F-sodium fluoride (18F-NaF) PET/CT is a sensitive imaging tool for bone and joint conditions.
  • It can distinguish between malignant and benign bone lesions, particularly with dynamic quantitative analysis.

Purpose of the Study:

  • To evaluate the potential of 18F-NaF PET/CT as a standard bone imaging modality.
  • To highlight its utility in diagnosing skeletal malignancies.

Main Methods:

  • Utilizing 18F-NaF PET/CT for bone lesion assessment.
  • Employing dynamic quantitative approaches for enhanced accuracy.

Main Results:

  • 18F-NaF PET/CT demonstrates high sensitivity and specificity in evaluating bone diseases.
Keywords:
(18)F-NaFBenign bone diseaseMalignant bone diseasePET/CTPET/MR imaging

Related Experiment Videos

  • The technique accurately differentiates malignant from benign bone lesions.

    • Conclusions:

    • High clinical accuracy, feasibility, and increasing availability support 18F-NaF PET/CT as a standard bone imaging method.
    • This modality is particularly valuable for skeletal malignant diseases.